The recent observation made in our laboratory that cellular myc (c-myc) mRNA has a very short half-life in a variety ofnormal and transformed human cells emphasized the potential importance of post-transcriptional regulation of c-myc gene expression. Jonak and Knight [Jonak, G. J. & Knight, E., Jr. (1984) Proc. NatI. Acad. Sci. USA 81, [1747][1748][1749][1750] have reported a selective reduction of c-myc mRNA accumulation in lymphoblastoid Daudi cells treated with human (3 interferon. This provided a suitable situation in which to examine a possible action of negative modulators of c-myc expression at the level of mRNA stability. Our results confirm the observation by Jonak and Knight that c-myc mRNA level is depressed in cells treated with i interferon and extend it to a2 interferon. Furthermore, we now demonstrate that interferon has no effect on c-myc transcription rate in isolated nuclei but rather reduces the half-life of its mRNA. Conversely, we show that it increases the level of HLA-A2 mRNA by stimulating its transcription.
The pathway that leads from a normal cell to a fully transformed one is controlled by at least two distinct classes of oncogenes acting in concert (for a review, see ref. 1 ). c-myc, the cellular homologue ofthe avian myelocytomatosis virus (MC29) oncogene, belongs to the establishment-immortalization class along with adenovirus Ela and the polyoma gene encoding the large tumor (T) antigen. To the second class, referred to as transforming genes, belong the ras family of oncogenes and the polyoma gene encoding middle T antigen.
The expression of the c-myc gene can be modulated in opposite directions. Enhanced expression of c-myc mRNA has been observed in a wide spectrum of neoplasms. It also can be induced experimentally early after mitogenic stimulation of lymphocytes by lipopolysaccharides or concanavalin A and offibroblasts by platelet-derived-growth factor (2) . Conversely, HL60, a human promyelocytic leukemia cell line, has been shown to respond by an early decrease in myc expression to agents that induce its granulocytic differentiation (3, 4) . Along the same vein, Jonak Several models of c-myc regulation by trans-acting elements, possibly repressors, have been proposed (6) (7) (8) . On the other hand, we have shown that c-myc mRNA is extremely unstable in both normal and transformed cells (9) , suggesting that it might, at least for a large part, be posttranscriptionally regulated at the level of its degradation. Thus, it was tempting to assess the contribution of transcriptional and post-transcriptional events to the effects of positive and negative modulators of c-myc expression. We selected IFNs as representatives of this latter type of modulators. The present results show that the reduced level of steady-state c-myc mRNA in IFN-treated cells can be accounted for by an increased rate of its degradation. A preliminary account of this work has recently been published in abstract form (10) . All techniques were as described previously (9) .
MATERIALS AND METHODS

Daudi
RESULTS
Hu-IFN-a2 (11) and Hu-IFN-,B (5, 11) (Fig. 2 a  and b ).
Since IFN did not affect c-myc or GAPDH in this system, it was important to assess the ability of our nuclear run-off assay to detect any modulation of gene transcriptional activity. Among the genes whose expression is enhanced by IFNs at both the protein and mRNA level are members of the major histocompatibility complex (20-25). As described in Fig. 2c , IFN increases HLA-A2 mRNA concentration in agreement with published data (23) (24) (25) . This accumulation of HLA-A2 mRNA in IFN-treated Daudi cells-results, at least in part, from an increase in its transcription rate (Fig. 2d) . It is worth noticing, however, that this enhanced rate of transcription is transient and returned to pretreatment level by 24 hr.
The above data suggest that the observed reduction in c-myc mRNA levels upon IFN treatment cannot be accounted for by differences in transcription rates and, therefore, must reflect a post-transcriptional regulation. This led us to search for a possible reduction in c-myc mRNA half-life as a result of IFN treatment. We have shown previously that actinomycin D could be used to determine c-myc mRNA turnover without grossly affecting post-transcriptional steps leading to its degradation (9) . Control cells or cells treated for 16 hr with Hu-IFN-a2 were exposed to high doses of actinomycin D to shut off all transcriptional activity. The survival of c-myc and GAPDH mRNAs in poly(A)+ RNA from cells taken at various times during the actinomycin D chase was determined on RNA blots. A typical experiment is shown in Fig. 3 Upper. Densitometric scanning of several autoradiographs from the same blots after different exposure times were combined to generate the kinetic curve of Fig. 3 Lower. Hybridization signals obtained with a GAPDH cDNA probe were used as an internal standard not affected by IFN (see Fig. 1 ). Under these conditions, we observed a 67-80%o reduction in c-myc mRNA half-life in IFN-treated cells as compared to control cells (Fig. 3 Lower).
DISCUSSION
The accelerated degradation of c-myc mRNA and the unaltered rate of transcription of c-myc gene that we report here are consistent with the observed 75-80% reduction in steady state c-myc mRNA levels after IFN treatment (5, 10 (-IFN) for 16 hr with 100 units of Hu-IFN-a2 per ml as described in Fig. 1 and were incubated further with 5 ,ug of actinomycin D per ml for the indicated times. For each time point, 10,tg of poly(A)+ RNA was prepared and analyzed as in Fig. 1 (26, 27) , histocompatibility antigens (23) (24) (25) , and a number of proteins of unknown functions (28) (29) (30) (31) (32) (33) . Although this was not the main purpose of these studies, it is worth noting that IFN increases rapidly but transiently the transcriptional activity of HLA-A2, whereas its mRNA accumulates over longer periods of time, in agreement with published data (23) (24) (25) Similar data reporting the absence of any significant modulation of the transcription rate of c-myc gene by IFN have been obtained recently (39) .
